{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:40:12Z","timestamp":1791567612533,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024075","name":"Region of Southern Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015223","name":"Danish Diabetes and Endocrine Academy","doi-asserted-by":"publisher","award":["NNF22SA0079901"],"award-info":[{"award-number":["NNF22SA0079901"]}],"id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF25OC0100796"],"award-info":[{"award-number":["NNF25OC0100796"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106648","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:08:26Z","timestamp":1778285306000},"page":"106648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-2078","authenticated-orcid":false,"given":"Mette","family":"B\u00f8gehave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Lehmann","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"T'Sjoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin den","family":"Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else-Marie","family":"Bladbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106648_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"10.1016\/j.rpth.2026.106648_bib2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/aogs.14227","article-title":"Gender incongruence in Denmark, a quantitative assessment","volume":"100","author":"Hilden","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.rpth.2026.106648_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/26895269.2020.1753136","article-title":"Epidemiological considerations in transgender health: a systematic review with focus on higher quality data","volume":"21","author":"Zhang","year":"2020","journal-title":"Int J Transgend Health"},{"key":"10.1016\/j.rpth.2026.106648_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.106648_bib5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.rpth.2026.106648_bib6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","article-title":"Cardiovascular disease in transgender people: a systematic review and meta-analysis","volume":"190","author":"van Zijverden","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.rpth.2026.106648_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/EJE-22-0306","article-title":"Cardiovascular risk in Danish transgender persons: a matched historical cohort study","volume":"187","author":"Glintborg","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.rpth.2026.106648_bib8","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.jtha.2025.03.006","article-title":"The thrombin generation potential increases after feminizing gender-affirming hormone treatment, decreases after masculinizing gender-affirming hormone treatment, and is determined by the hormone treatment regimen","volume":"23","author":"B\u00f8gehave","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib9","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106648_bib10","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.106648_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.12229","article-title":"Fibrin(ogen) and thrombotic disease","volume":"11","author":"Ari\u00ebns","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2021.06.024","article-title":"Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction","volume":"205","author":"Siniarski","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106648_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1538-7836.2007.02362.x","article-title":"Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay","volume":"5","author":"Curnow","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1160\/TH06-12-0715","article-title":"Fibrin clot structure in patients with end-stage renal disease","volume":"98","author":"Sj\u00f8land","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/biom14020230","article-title":"Comprehensive analysis of the role of fibrinogen and thrombin in clot formation and structure for plasma and purified fibrinogen","volume":"14","author":"Risman","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.rpth.2026.106648_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261312","article-title":"The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis","volume":"17","author":"Schutte","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106648_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2024.02.029","article-title":"Effects of gender affirming hormone therapy with testosterone on coagulation and hematological parameters in transgender people assigned female at birth: a systematic review and meta-analysis","volume":"236","author":"Tienforti","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106648_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa262","article-title":"Global coagulation assays in transgender women on oral and transdermal estradiol therapy","volume":"105","author":"Lim","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2026.106648_bib20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1160\/TH16-10-0748","article-title":"Fibrin clot structure\u2014pro-fibrinolytic effect of oral contraceptives in apparently healthy women","volume":"117","author":"Sidelmann","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0040-1714398","article-title":"Anabolic\u2013androgenic steroid abuse impairs fibrin clot lysis","volume":"47","author":"Sidelmann","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106648_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.eurpsy.2010.04.009","article-title":"A European network for the investigation of gender incongruence: the ENIGI initiative","volume":"27","author":"Kreukels","year":"2012","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.rpth.2026.106648_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jsxm.2016.03.371","article-title":"A European network for the investigation of gender incongruence: endocrine part","volume":"13","author":"Dekker","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.rpth.2026.106648_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"10.1016\/j.rpth.2026.106648_bib25","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/jc.2018-02138","article-title":"Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen","volume":"104","author":"van Velzen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2026.106648_bib26","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.rpth.2026.106648_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/ma60061a009","article-title":"Size and density of fibrin fibers from turbidity","volume":"11","author":"Carr","year":"1978","journal-title":"Macromolecules"},{"key":"10.1016\/j.rpth.2026.106648_bib28","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/ma60078a022","article-title":"Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity","volume":"13","author":"Carr","year":"1980","journal-title":"Macromolecules"},{"key":"10.1016\/j.rpth.2026.106648_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.15531","article-title":"Why fibrin biomechanical properties matter for hemostasis and thrombosis","volume":"20","author":"Feller","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2015-06-652214","article-title":"Thrombin and fibrinogen \u03b3' impact clot structure by marked effects on intrafibrillar structure and protofibril packing","volume":"127","author":"Domingues","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106648_bib31","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.jtha.2023.08.014","article-title":"Fibrinogen and fibrin: synthesis, structure, and function in health and disease","volume":"21","author":"Wolberg","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106648_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jwh.2011.2839","article-title":"Are all estrogens created equal? A review of oral vs. transdermal therapy","volume":"21","author":"Goodman","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.rpth.2026.106648_bib34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1670639","article-title":"Anabolic androgenic steroid abuse: the effects on thrombosis risk, coagulation, and fibrinolysis","volume":"44","author":"Chang","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106648_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43556-024-00214-x","article-title":"Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation","volume":"5","author":"Nencini","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.rpth.2026.106648_bib36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2017-03-745349","article-title":"Red blood cells in thrombosis","volume":"130","author":"Byrnes","year":"2017","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926033066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926033066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:24:35Z","timestamp":1784546675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926033066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926033066"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106648","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106648"}}